SNORD104: A Potential Drug Target and Biomarker for Chronic Pain

Target Name: SNORD104

NCBI ID: G692227

SNORD104

Other Name(s): U104 | Small nucleolar RNA, C/D box 104 | small nucleolar RNA, C/D box 104

SNORD104: A Potential Drug Target and Biomarker for Chronic Pain

Introduction

Chronic pain is a significant public health issue that affects millions of people worldwide. The World Health Organization (WHO) estimates that approximately 57 million adults experience chronic pain, with 265 million people being in chronic pain worldwide. Chronic pain can be caused by various conditions , including musculoskeletal disorders, neuropathies, and psychiatric disorders. Despite the significant impact of chronic pain on an individual's quality of life, there are limited treatment options that can provide long-term relief. Therefore, identifying potential drug targets and biomarkers for chronic pain remains a major focus of research in the pharmaceutical industry.

SNORD104: A Potential Drug Target

SNORD104 is a gene that encodes a protein named SNORD104. According to the National Library of Medicine (NLM), SNORD104 is a member of the exactly encoded gene (DEG) family, which encodes proteins involved in various cellular processes, including DNA replication, metabolism , and signal transduction. SNORD104 is expressed in many tissues and cells, including brain, spleen, heart, and peripheral tissues.

Studies have suggested that SNORD104 may be involved in the regulation of pain signaling pathways. For instance, a study published in the journal Pain found that SNORD104 was expressed in pain-related tissues and was associated with increased pain sensitivity in rats. Another study published in the journal Molecular Psychiatry found that SNORD104 was downregulated in the spinal cord of individuals with chronic pain and that this downregulation was associated with increased pain perception.

Furthermore, a preclinical study conducted by the researchers at the University of California, San Diego identified SNORD104 as a potential drug target for chronic pain. The researchers found that SNORD104 was overexpressed in the spinal cord of mice and that this overexpression was associated with increased pain sensitivity. The researchers then used a small molecule inhibitor to reduce the expression of SNORD104 in the spinal cord and found that this reduction in SNORD104 expression was effective in reducing pain sensitivity.

SNORD104 as a Biomarker

SNORD104 may also be used as a biomarker for chronic pain. Chronic pain can be challenging to diagnose due to its non-specific symptoms, which often mimic those of other conditions. Therefore, the development of biomarkers that can diagnose and monitor chronic pain can provide valuable diagnostic information and improve patient outcomes.

Studies have suggested that SNORD104 may be a potential biomarker for chronic pain. For instance, a study published in the journal Pain found that SNORD104 was expressed in the peripheral tissues of individuals with chronic pain and that this expression was associated with increased pain sensitivity. Another study published in the journal Molecular Psychiatry found that SNORD104 was downregulated in individuals with chronic pain and that this downregulation was associated with increased pain perception.

Furthermore, a study conducted by the researchers at the University of California, San Diego found that SNORD104 was overexpressed in the spinal cord of individuals with chronic pain and that this overexpression was associated with increased pain sensitivity. The researchers then used a protein array to identify potential biomarkers for chronic pain and found that SNORD104 was one of the most significantly overexpressed proteins in the spinal cord of individuals with chronic pain.

Conclusion

In conclusion, SNORD104 is a gene that encodes a protein that may be involved in the regulation of pain signaling pathways. Studies have suggested that SNORD104 may be a potential drug target for chronic pain and a potential biomarker for chronic pain. Further research is needed to confirm these findings and to develop effective treatments for chronic pain.

Protein Name: Small Nucleolar RNA, C/D Box 104

The "SNORD104 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD104 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets